[10] HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda. Retrieved June 21, 2024 ...

FRUZAQLA is not chemotherapy. It is a targeted therapy that affects vascular endothelial growth factor (VEGF) receptors, ...

"We also found that in colorectal cancer patients, those with low levels of EV-DNA in their tumors at the time of diagnosis were more likely to develop liver metastases later on, compared to those ...

Liver Transplant Outperforms Other Therapies for Colorectal Cancer That Has Spread to the Liver July 30, 2024 — A study followed patients whose colorectal cancer was under control, but who had ...

Metastatic bowel cancer is cancer that has spread from the back passage (rectum) and large intestines (colon) to other parts of the body, such as the liver. Sometimes cancer has spread when it is ...

The following is a summary of “myCAF-derived exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine ...

“These findings confirmed that CDT is essential for the bacteria’s role in promoting cancer spread,” Jobin said. “When bacteria that produce CDT move to tumors outside the gut, it appears to ...

Kupffer cells or liver macrophages were also identified ... and a significant increase in metastasis in colorectal cancer models. Importantly, EVs with low DNA content failed to induce the immune ...

Using laboratory mice with metastatic lung and liver tumors, human colorectal cancer tissue, and 3D colorectal cancer tumor models made from patient cells, the researchers showed how the bacterial ...

BI-765049 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Metastatic Colorectal Cancer.